Lennar (LEN) Investors: Wedbush Reconfirms “Neutral” Rating, Sees $60.00/Share; Retractable Technologies (NYSEAMERICAN:RVP) Shorts Down By 58.4%

Retractable Technologies Incorporated (NYSEAMERICAN:RVP) had a decrease of 58.4% in short interest. RVP’s SI was 60,700 shares in December as released by FINRA. Its down 58.4% from 145,900 shares previously. With 107,200 avg volume, 1 days are for Retractable Technologies Incorporated (NYSEAMERICAN:RVP)’s short sellers to cover RVP’s short positions. The SI to Retractable Technologies Incorporated’s float is 0.94%. The stock increased 2.36% or $0.02 during the last trading session, reaching $0.68. About 165,068 shares traded. Retractable Technologies, Inc. (NYSEAMERICAN:RVP) has declined 52.59% since December 31, 2016 and is downtrending. It has underperformed by 69.29% the S&P500.

Among 24 analysts covering Lennar (NYSE:LEN), 15 have Buy rating, 0 Sell and 9 Hold. Therefore 63% are positive. Lennar has $77 highest and $45 lowest target. $59.71’s average target is -5.58% below currents $63.24 stock price. Lennar had 55 analyst reports since September 22, 2015 according to SRatingsIntel. The stock of Lennar Corporation (NYSE:LEN) earned “Buy” rating by Argus Research on Tuesday, July 25. As per Wednesday, October 4, the company rating was upgraded by M Partners. RBC Capital Markets maintained the stock with “Buy” rating in Thursday, July 13 report. On Thursday, October 19 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”. KeyBanc Capital Markets maintained the stock with “Hold” rating in Tuesday, September 26 report. The firm earned “Outperform” rating on Wednesday, March 30 by Wood. On Monday, June 27 the stock rating was upgraded by Raymond James to “Outperform”. On Wednesday, September 21 the stock rating was maintained by Citigroup with “Neutral”. The firm earned “Overweight” rating on Wednesday, March 30 by Barclays Capital. As per Wednesday, June 21, the company rating was downgraded by Evercore.

Investors sentiment decreased to 0.92 in 2017 Q3. Its down 0.28, from 1.2 in 2017Q2. It dived, as 44 investors sold Lennar Corporation shares while 148 reduced holdings. 45 funds opened positions while 132 raised stakes. 187.83 million shares or 0.17% more from 187.51 million shares in 2017Q2 were reported. Credit Agricole S A reported 0.03% in Lennar Corporation (NYSE:LEN). Wafra Invest Advisory Grp Inc holds 102,408 shares or 0.26% of its portfolio. Tcw Group holds 1.38% or 3.28M shares in its portfolio. Commonwealth Equity Inc stated it has 0% in Lennar Corporation (NYSE:LEN). Asset Management Advsrs Lc stated it has 3.93% of its portfolio in Lennar Corporation (NYSE:LEN). Bb&T Securities Limited Liability Company stated it has 0.07% in Lennar Corporation (NYSE:LEN). Alliancebernstein Limited Partnership holds 2.14M shares. Invest Of Virginia Ltd Liability Corporation holds 0.37% or 29,880 shares in its portfolio. Mu Invests Co Limited holds 0.03% of its portfolio in Lennar Corporation (NYSE:LEN) for 680 shares. Deutsche State Bank Ag holds 0.03% in Lennar Corporation (NYSE:LEN) or 723,080 shares. Pub Sector Pension Board invested in 22,571 shares. Robeco Institutional Asset Bv holds 0% or 8,697 shares in its portfolio. 528,477 are held by Nomura. Sei Investments holds 0.02% of its portfolio in Lennar Corporation (NYSE:LEN) for 126,699 shares. Dynamic Capital Mgmt holds 0.14% or 9,354 shares.

Lennar Corporation, together with its subsidiaries, engages in the homebuilding activities in the United States. The company has market cap of $14.79 billion. The firm operates through Homebuilding East, Homebuilding Central, Homebuilding West, Lennar Financial Services, Rialto, and Lennar Multifamily divisions. It has a 18.59 P/E ratio. The Company’s homebuilding activities primarily include the construction and sale of single-family attached and detached homes to first-time, move-up, and active adult homebuyers, as well as the purchase, development, and sale of residential land.

Analysts await Lennar Corporation (NYSE:LEN) to report earnings on January, 10 before the open. They expect $1.50 earnings per share, up 11.94% or $0.16 from last year’s $1.34 per share. LEN’s profit will be $350.83 million for 10.54 P/E if the $1.50 EPS becomes a reality. After $1.06 actual earnings per share reported by Lennar Corporation for the previous quarter, Wall Street now forecasts 41.51% EPS growth.

Since October 2, 2017, it had 0 insider buys, and 2 selling transactions for $1.90 million activity. GROSS BRUCE E also sold $847,200 worth of Lennar Corporation (NYSE:LEN) shares. On Monday, October 2 JAFFE JONATHAN M sold $1.06M worth of Lennar Corporation (NYSE:LEN) or 20,000 shares.

The stock decreased 0.91% or $0.58 during the last trading session, reaching $63.24. About 2.13 million shares traded. Lennar Corporation (NYSE:LEN) has risen 19.91% since December 31, 2016 and is uptrending. It has outperformed by 3.21% the S&P500.

Retractable Technologies, Inc. designs, develops, makes, and markets safety syringes and other safety medical products for the healthcare industry in the United States and internationally. The company has market cap of $22.21 million. The Company’s principal products comprise VanishPoint 0.5mL insulin syringes; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; EasyPoint needles; VanishPoint blood collection tube holders; VanishPoint IV safety catheters; small diameter tube adapters; allergy trays; Patient Safe syringes; Patient Safe Luer caps; and VanishPoint blood collection sets, as well as VanishPoint autodisable syringes. It currently has negative earnings. The firm is also developing retractable needles and syringes, glass syringes, dental syringes, IV catheter introducers, and blood collection sets.